Published in Eur Child Adolesc Psychiatry on January 30, 2006
Psychiatric diagnosis - is it universal or relative to culture? J Child Psychol Psychiatry (2008) 1.73
Efficacy and safety of atomoxetine as add-on to psychoeducation in the treatment of attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in stimulant-naïve Swedish children and adolescents. Eur Child Adolesc Psychiatry (2009) 1.10
Co-existing psychiatric problems in ADHD in the ADORE cohort. Eur Child Adolesc Psychiatry (2006) 0.91
The prevalence of Attention Deficit Hyperactivity Disorder in Iran: A systematic review. Iran J Psychiatry (2010) 0.84
Baseline characteristics of European and non-European adult patients with attention deficit hyperactivity disorder participating in a placebo-controlled, randomized treatment study with atomoxetine. Child Adolesc Psychiatry Ment Health (2013) 0.83
Packages of care for attention-deficit hyperactivity disorder in low- and middle-income countries. PLoS Med (2010) 0.81
Why does the worldwide prevalence of childhood attention deficit hyperactivity disorder matter? Am J Psychiatry (2007) 0.80
Daily life impairments associated with childhood/adolescent attention-deficit/hyperactivity disorder as recalled by adults: results from the European Lifetime Impairment Survey. CNS Spectr (2014) 0.78
Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet (1998) 5.34
Evolution and revolution in child psychiatry: ADHD as a disorder of adaptation. J Am Acad Child Adolesc Psychiatry (1997) 3.98
Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry (2002) 3.89
Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry (1997) 3.56
Gender differences in ADHD: a meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry (1997) 3.08
Attention-deficit/hyperactivity disorder in adults: an overview. Biol Psychiatry (2000) 2.80
Attention deficit hyperactivity disorder adults: comorbidities and adaptive impairments. Compr Psychiatry (1997) 2.49
Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics (2001) 2.48
Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry (2002) 2.37
The comorbidity of ADHD in the general population of Swedish school-age children. J Child Psychol Psychiatry (2001) 2.10
Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry (1997) 2.06
Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder. J Clin Psychiatry (2002) 2.00
Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol Psychiatry (1999) 1.85
Symptom profiles in children with ADHD: effects of comorbidity and gender. J Am Acad Child Adolesc Psychiatry (2001) 1.76
Validity of DSM-IVADHD subtypes in a nationally representative sample of Australian children and adolescents. J Am Acad Child Adolesc Psychiatry (2001) 1.54
Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry (2004) 1.23
Neuropsychological function in adults with attention-deficit hyperactivity disorder. Biol Psychiatry (1998) 1.23
ADHD in a school sample of Brazilian adolescents: a study of prevalence, comorbid conditions, and impairments. J Am Acad Child Adolesc Psychiatry (1999) 1.10
ADHD-related behavior among non-referred children: parents' ratings of DSM-III-R symptoms. Child Psychiatry Hum Dev (1994) 0.99
Attention-deficit hyperactivity disorder in Manitoba children: medical diagnosis and psychostimulant treatment rates. Can J Psychiatry (2001) 0.98
Prevalence of attention deficit hyperactivity disorder in primary school children in Taiwan. J Formos Med Assoc (1993) 0.92
Comparison of the role of dopamine, serotonin, and noradrenaline genes in ADHD, ODD and conduct disorder: multivariate regression analysis of 20 genes. Clin Genet (2000) 0.91
A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHD. Eur Child Adolesc Psychiatry (2004) 0.90
Appropriateness of psychostimulant prescription to children: theoretical and empirical perspectives. Can J Psychiatry (1999) 0.88
[Study of the prevalence of the attention deficit hyperactivity disorder in ten-year-old children living in the Valencia metropolitan area]. Actas Luso Esp Neurol Psiquiatr Cienc Afines (1995) 0.80
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet (2003) 15.31
Functional impact of global rare copy number variation in autism spectrum disorders. Nature (2010) 14.66
Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet (2007) 14.05
Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet (2006) 11.14
Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry (2013) 5.89
Computerized training of working memory in children with ADHD--a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry (2005) 5.58
The worldwide prevalence of ADHD: is it an American condition? World Psychiatry (2003) 5.30
The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood. Am J Psychiatry (2010) 4.92
A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet (2010) 3.42
Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response. Am J Psychiatry (2008) 3.34
European clinical guidelines for hyperkinetic disorder -- first upgrade. Eur Child Adolesc Psychiatry (2004) 3.22
Patterns of brain injury in term neonatal encephalopathy. J Pediatr (2005) 2.86
Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet (2012) 2.65
Autism after adolescence: population-based 13- to 22-year follow-up study of 120 individuals with autism diagnosed in childhood. J Autism Dev Disord (2005) 2.59
Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry (2006) 2.49
The quality of life of children with attention deficit/hyperactivity disorder: a systematic review. Eur Child Adolesc Psychiatry (2009) 2.47
Individual common variants exert weak effects on the risk for autism spectrum disorderspi. Hum Mol Genet (2012) 2.46
Excess of high frequency electroencephalogram oscillations in boys with autism. Biol Psychiatry (2007) 2.15
Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet (2010) 2.14
Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial. J Am Acad Child Adolesc Psychiatry (2002) 2.10
Cardiovascular effects of atomoxetine in children, adolescents, and adults. Drug Saf (2003) 2.07
Autism spectrum disorders in children with active epilepsy and learning disability: comorbidity, pre- and perinatal background, and seizure characteristics. Dev Med Child Neurol (2003) 2.06
Psychiatric and psychosocial problems in adults with normal-intelligence autism spectrum disorders. BMC Psychiatry (2009) 2.03
Adolescent-onset anorexia nervosa: 18-year outcome. Br J Psychiatry (2009) 2.03
[Children and young people with neurodevelopmental problems: Support and efforts must be given even if not all diagnostic criteria are met]. Lakartidningen (2013) 1.95
Psychiatric disorders in Norwegian 8- to 10-year-olds: an epidemiological survey of prevalence, risk factors, and service use. J Am Acad Child Adolesc Psychiatry (2007) 1.90
Autism spectrum disorders in children with normal intellectual levels: associated impairments and subgroups. Dev Med Child Neurol (2004) 1.87
Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant. Neurology (2012) 1.83
Psychiatric telephone interview with parents for screening of childhood autism - tics, attention-deficit hyperactivity disorder and other comorbidities (A-TAC): preliminary reliability and validity. Br J Psychiatry (2005) 1.69
Autism spectrum disorders and autistic like traits: similar etiology in the extreme end and the normal variation. Arch Gen Psychiatry (2012) 1.66
Autism spectrum disorders in the DSM-V: better or worse than the DSM-IV? Res Dev Disabil (2011) 1.65
Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. Am J Med Genet B Neuropsychiatr Genet (2007) 1.65
Asperger syndrome and autism: a comparative longitudinal follow-up study more than 5 years after original diagnosis. J Autism Dev Disord (2007) 1.65
Health-related quality of life of children and adolescents with mental disorders. J Am Acad Child Adolesc Psychiatry (2002) 1.64
Serum levels of 25-hydroxyvitamin D in mothers of Swedish and of Somali origin who have children with and without autism. Acta Paediatr (2010) 1.62
Screening for the attention deficit hyperactivity disorder phenotype using the strength and difficulties questionnaire. Eur Child Adolesc Psychiatry (2011) 1.60
SHANK1 Deletions in Males with Autism Spectrum Disorder. Am J Hum Genet (2012) 1.59
Impact of responder definition on the enriched enrollment randomized withdrawal trial design for establishing proof of concept in neuropathic pain. Pain (2010) 1.59
Psychiatric comorbidity in young adults with a clinical diagnosis of Asperger syndrome. Res Dev Disabil (2011) 1.59
The Autism--Tics, AD/HD and other Comorbidities (A-TAC) telephone interview: convergence with the Child Behavior Checklist (CBCL). Nord J Psychiatry (2010) 1.56
Clinical practice guidelines for depression in young people: are the treatment recommendations outdated? Med J Aust (2002) 1.56
Autistic features in a total population of 7-9-year-old children assessed by the ASSQ (Autism Spectrum Screening Questionnaire). J Child Psychol Psychiatry (2006) 1.55
Effects of atomoxetine on growth after 2-year treatment among pediatric patients with attention-deficit/hyperactivity disorder. Pediatrics (2005) 1.52
The impact of ADHD and autism spectrum disorders on temperament, character, and personality development. Am J Psychiatry (2006) 1.51
A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee. Pain Pract (2011) 1.50
Autism, ADHD, mental retardation and behavior problems in 100 individuals with 22q11 deletion syndrome. Res Dev Disabil (2008) 1.49
Autism spectrum disorder in children with and without epilepsy: impact on social functioning and communication. Acta Paediatr (2009) 1.49
No association between the 2D:4D fetal testosterone marker and multidimensional attentional abilities in children with ADHD. Dev Med Child Neurol (2010) 1.48
Autism in adults: symptom patterns and early childhood predictors. Use of the DISCO in a community sample followed from childhood. J Child Psychol Psychiatry (2007) 1.48
Autism before diagnosis: crying, feeding and sleeping problems in the first two years of life. Acta Paediatr (2013) 1.44
The autism--tics, AD/HD and other comorbidities inventory (A-TAC): further validation of a telephone interview for epidemiological research. BMC Psychiatry (2010) 1.43
A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder. Hum Genet (2011) 1.43
A 7 Mb duplication at 22q13 in a girl with bipolar disorder and hippocampal malformation. Am J Med Genet A (2008) 1.41
[Children and adolescents with developmental disabilities. The spectrum of disorders requires a care team with broad competence]. Lakartidningen (2007) 1.40
The importance of screening for ADHD in children and adolescents with obesity. Acta Paediatr (2013) 1.39
Voice-DISC identified DSM-IV disorders among 15-year-olds in the west of Scotland. J Am Acad Child Adolesc Psychiatry (2003) 1.38
Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns. Eur Neuropsychopharmacol (2009) 1.36
Meta-analysis of suicide-related behavior events in patients treated with atomoxetine. J Am Acad Child Adolesc Psychiatry (2008) 1.35
The Child and Adolescent Twin Study in Sweden (CATSS). Twin Res Hum Genet (2011) 1.33
Screening for genomic rearrangements and methylation abnormalities of the 15q11-q13 region in autism spectrum disorders. Biol Psychiatry (2009) 1.32
Chronic physical illness and mental health in children. Results from a large-scale population study. J Child Psychol Psychiatry (2007) 1.31
Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. J Child Psychol Psychiatry (2013) 1.29
Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies. BMC Psychiatry (2013) 1.29
One hundred males with Asperger syndrome: a clinical study of background and associated factors. Dev Med Child Neurol (2004) 1.28
Attention deficits in children with 22q.11 deletion syndrome. Dev Med Child Neurol (2005) 1.27
Highly efficient syntheses of azetidines, pyrrolidines, and indolines via palladium catalyzed intramolecular amination of C(sp3)-H and C(sp2)-H bonds at γ and δ positions. J Am Chem Soc (2011) 1.26
EINAQ -- a European educational initiative on Attention-Deficit Hyperactivity Disorder and associated problems. Eur Child Adolesc Psychiatry (2004) 1.26
The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder. J Dev Behav Pediatr (2004) 1.26
The Autism Spectrum Screening Questionnaire (ASSQ)-Revised Extended Version (ASSQ-REV): an instrument for better capturing the autism phenotype in girls? A preliminary study involving 191 clinical cases and community controls. Res Dev Disabil (2011) 1.25
Progress toward treatments for synaptic defects in autism. Nat Med (2013) 1.24
Expression and genetic variability of PCDH11Y, a gene specific to Homo sapiens and candidate for susceptibility to psychiatric disorders. Am J Med Genet B Neuropsychiatr Genet (2006) 1.24
European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder. Eur Neuropsychopharmacol (2013) 1.23
Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry (2004) 1.23
Autism spectrum disorder diagnoses in Stockholm preschoolers. Res Dev Disabil (2010) 1.21
Practitioner review: Quality of life in child mental health--conceptual challenges and practical choices. J Child Psychol Psychiatry (2009) 1.21
Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug Alcohol Depend (2008) 1.21
Mobius sequence--a Swedish multidiscipline study. Eur J Paediatr Neurol (2002) 1.20
Epilepsy in young adults with autism: a prospective population-based follow-up study of 120 individuals diagnosed in childhood. Epilepsia (2005) 1.20
MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer. FEBS Lett (2010) 1.19
Occupational outcome in adult ADHD: impact of symptom profile, comorbid psychiatric problems, and treatment: a cross-sectional study of 414 clinically diagnosed adult ADHD patients. J Atten Disord (2009) 1.18
Aspects of quality of life in adults diagnosed with autism in childhood: a population-based study. Autism (2010) 1.18
Predicting nonresponse bias from teacher ratings of mental health problems in primary school children. J Abnorm Child Psychol (2007) 1.17
Treatment approaches to major depressive disorder relapse. Part 2: reinitiation of antidepressant treatment. Psychother Psychosom (2002) 1.17
Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms. J Am Acad Child Adolesc Psychiatry (2005) 1.17
Autism and auditory brain stem responses. Ear Hear (2003) 1.17
Neuropsychiatric and neurodevelopmental outcome of children at age 6 and 7 years who screened positive for language problems at 30 months. Dev Med Child Neurol (2006) 1.15
Trajectories leading to autism spectrum disorders are affected by paternal age: findings from two nationally representative twin studies. J Child Psychol Psychiatry (2010) 1.14
Oculo-auriculo-vertebral spectrum: associated anomalies, functional deficits and possible developmental risk factors. Am J Med Genet A (2007) 1.14
Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial. J Pain (2010) 1.14
Prevalence of autism in children born to Somali parents living in Sweden: a brief report. Dev Med Child Neurol (2008) 1.13
Treatment approaches to major depressive disorder relapse. Part 1: dose increase. Psychother Psychosom (2002) 1.13